, Références : 1-INCa, suivi du dispositif de prise en charge et de recherche clinique en oncogériatrie : Etat des lieux au 1 er janvier, INCA, p.34, 2015.

M. Arnold, H. E. Karim-kos, and J. W. Coebergh, Recent trends in incidence of five common cancers in 26 European countries since 1988 : analysis of the European Cancer Observatory

, Eur J Cancer, vol.51, pp.1164-87, 2015.

R. L. Siegel, K. D. Miller, and A. Jemal, Cancer statistics, CA Cancer, vol.66, pp.7-30, 2016.

H. Wildiers, P. Heeren, and M. Puts, International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer, J Clin Oncol, 2014.

S. G. Mohile, W. Dale, and M. R. Somerfield, Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology, J Clin Oncol, vol.36, issue.22, pp.2326-2373, 2018.

P. Soubeyran, C. Bellera, and J. Goyard, Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study, PLoS One, issue.12, p.115060, 2014.

R. Carmel and L. Eisenberg, Serum vitamin B12 and transcobalamin abnormalities in patients with cancer, Cancer, vol.40, issue.3, pp.1348-53, 1977.

A. A. -ermens, L. T. Vlasveld, and J. Lindemans, Significance of elevated cobalamin (vitamin B12) levels in blood, Clin Biochem, vol.36, pp.585-90, 2003.

E. Andres, K. Serraj, and J. Zhu, The pathophysiology of elevated vitamin B12 in clinical practice, Q J Med, vol.106, pp.505-515, 2013.

P. Geissbühler, B. Mermillod, and C. Rapin, Elevated Serum Vitamin B12 Levels Associated With CRP as a Predictive Factor of Mortality in Palliative Care Cancer Patients: A Prospective Study Over Five Years, Journal of Pain and Symptom Management. 1 août, vol.20, issue.2, pp.93-103, 2000.

N. Salles, F. Herrmann, and K. Sakbani, High vitamin b12 level: a strong predictor of mortality in elderly inpatients: letters to the editor, Journal of the American Geriatrics Society, vol.53, issue.5, pp.917-925, 2005.

L. Kelly, S. White, and P. Stone, The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study, Annals of Oncology. août, vol.18, issue.8, pp.1395-1404, 2007.

C. Grassa, Enquête d opinion auprès des médecins généralistes des Alpes Maritimes sur l' intérêt de l'évaluation onco-gériatrique -PDF

;. Disponible, S. Servent, V. Gaxatte, and C. , La détection précoce des cancers du sein chez les femmes âgées de 75 ans et plus dans le département du Nord, JOG, vol.10, issue.1, pp.13-24, 2019.

S. Katz, A. B. Ford, and R. W. Moskowitz, Studies of illness in the aged: the index of ADL, a standardized measure of biological and psychological function, JAMA, vol.185, pp.914-919, 1963.

M. P. Lawton and E. M. Brody, Assessment of older people: self-maintaining and instrumental activities of daily living, Gerontologist, vol.9, pp.179-186, 1969.

D. -podsiadlo and S. Richardson, The timed up and go: A test of basic functional mobility for frail elderly persons, J Am Geriatr Soc, vol.39, pp.142-150, 1991.

B. J. Vellas, S. J. Wayne, and L. Romero, One-leg balance is an important predictor of injurious falls in older persons, J Am Geriatr Soc, vol.4, pp.735-738, 1997.

P. J. Friedman, D. E. Richmond, and J. J. Baskett, A prospective trial of serial gait speed as a measure of rehabilitation in the elderly, Age Ageing, vol.17, issue.4, pp.227-262, 1988.

M. M. -oken, R. H. Creech, and D. C. Tormey, Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, vol.5, issue.6, pp.649-55, 1982.

Y. Guigoz, S. Lauque, and B. J. Vellas, Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment, Clin Geriatr Med, vol.18, issue.4, pp.737-57, 2002.

S. J. Lee, K. Lindquist, and M. R. Segal, Development and validation of a prognostic index for 4-year mortality in older adults, JAMA, vol.295, pp.801-808, 2006.

L. C. Walter, R. J. Brand, and S. R. Counsell, Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization, JAMA, vol.285, pp.2987-2994, 2001.

L. -chiche, J. R. Romain, and F. , Clinical implications of high cobalamin blood levels for internal medicine, Rev Med Interne. mars, vol.29, issue.3, pp.187-94, 2008.

J. Arendt, L. Pedersen, E. Nexo, and H. T. Sørensen, Elevated Plasma Vitamin B12 Levels as a Marker for Cancer: A Population-Based Cohort Study, J Natl Cancer Inst. 4 déc, vol.105, issue.23, pp.1799-805, 2013.

T. Deneuville, N. Mario, and K. P. Tiev, Concentration plasmatique élevée de la vitamine B12 : un indicateur des maladies hépatiques ou tumorales, Rev Med Interne, vol.30, issue.2, p.73, 2009.

S. M. Collin, C. Metcalfe, and H. Refsum, Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis, Cancer Epidemiol Biomarkers Prev, vol.19, issue.6, pp.1632-1642, 2010.

M. Johansson, C. Relton, and P. M. Ureland, Serum B vitamin levels and risk of lung cancer, JAMA, vol.303, issue.23, pp.2377-2385, 2010.

E. Andres, K. Serraj, J. Zhu, and A. Vermorken, The pathophysiology of elevated vitamin B12 in clinical practice, QJM. 1 juin, vol.106, issue.6, pp.505-520, 2013.

S. P. Kane, I. M. Murray-lyon, and F. J. Paradinas, Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma, Gut, vol.19, pp.1105-1114, 1978.

S. Tal, Y. Shavit, and F. Stern, Association between vitamin B12 levels and mortality in hospitalized older adults, J Am Geriatr Soc, vol.58, pp.523-529, 2010.

A. A. -zulfiqar, R. Mahmoudi, and A. Sebaux, P333: Prospective study of hypervitaminosis B12 in acute geriatric unit: advance results, European Geriatric Medicine. sept, vol.5, pp.186-193, 2014.

T. Aparicio, J. L. Jouve, and L. Teillet, Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients, J Clin Oncol, vol.31, pp.1464-70, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02088193

M. E. Hamaker, B. M. Buurman, and B. C. Van-munster, The value of a comprehensive geriatric assessment for patient care in acutely hospitalized older patients with cancer Oncologist, vol.16, pp.1403-1415, 2011.

A. L. Couderc, R. Boulahssass, and E. Nouguerede, Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study, Crit Rev Oncol Hematol, vol.78, issue.2, pp.138-187, 2011.

C. Kenis, L. Decoster, and J. Bastin, Functional decline in older patients with cancer receiving chemotherapy: A multicenter prospective study, J Geriatr Oncol, vol.8, issue.3, pp.196-205, 2017.

E. Ferrat, E. Paillaud, and M. Laurent, ELPACA Study Group. Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer, J Gerontol A Biol Sci Med Sci, vol.70, issue.9, pp.1148-55, 2015.

-. , Stratégies de prise en charge en cas de dénutrition protéino-énergétique chez la personne âgée, 2007.

P. Soubeyran, M. Fonck, and C. Blanc-bisson, Predictors of early death risk in older patients treated with first-line chemotherapy for cancer, J Clin Oncol, vol.30, pp.1829-1834, 2012.

R. -boulahssass, S. Gonfrier, and J. M. Ferrero, Predicting early death in older adults with cancer, Eur J Cancer, vol.100, pp.65-74, 2018.

F. Pamoukdjian, V. Levy, and G. Sebbane, Slow gait speed is an independent predictor of early death in older cancer outpatients: results from a prospective cohort study, J Nutr Health Aging, vol.21, issue.2, pp.202-206, 2017.

F. Pamoukdjian, T. Aparicio, and S. Zebachi, Comparison of mobility indices for predicting early death in older patients with cancer: the PF-EC cohort study, J Gerontol A Biol Sci Med Sci, 2019.

M. Cesari, S. B. Kritchevsky, and B. W. Penninx, Prognostic value of usual gait speed in well-functioning older people. Results from the Health, Aging and Body Composition Study, J Am Geriatr Soc, vol.53, issue.10, pp.1675-1680, 2005.

M. -montero-odasso, M. Schapira, and E. R. Soriano, Gait velocity as a single predictor of adverse events in healthy seniors aged 75 years and older, J Gerontol A Biol Sci Med Sci, vol.60, issue.10, pp.1304-1309, 2005.

L. Decoster, C. Kenis, D. Schallier, J. Vansteenkiste, K. Nackaerts et al., Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study, Crit Rev Oncol Hematol. mai, vol.195, issue.5, pp.138-187, 2011.

M. Extermann, I. Boler, and R. R. Reich, Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score, Cancer, vol.118, pp.3377-86, 2012.

A. -hurria, S. Mohile, and A. Gajra, Validation of a prediction tool for chemotherapy toxicity in older adults with cancer, J Clin Oncol, vol.34, pp.2366-2371, 2016.